Bailard’s Artiva Biotherapeutics ARTV Stock Holding History

Bailard’s Portfolio ARTV Stock Details ARTV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$147K	Hold	20,700	–	–	﹤0.01%	733
2026 Q2	$201K	Hold	20,700	–	–	﹤0.01%	737
2026 Q1	$133K	Buy	+20,700	New	+$102K	﹤0.01%	715

Other funds holding ARTV

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Bailard's ARTV Position: Q3 2026 in Review

Bailard held its Artiva Biotherapeutics (ARTV) position steady in Q3 2026 at 20,700 shares worth $147K. The position accounts for ﹤0.01% of the portfolio, ranked #733.

Bailard first reported a position in ARTV in Q1 2026 and has held it in 3 quarters since. The position peaked at $201K in Q2 2026. 3 funds tracked by Wall St. Rank hold ARTV as of Q3 2026.

Bailard held 20,700 shares of Artiva Biotherapeutics worth $147K as of Q3 2026.
Bailard left its Artiva Biotherapeutics share count unchanged in Q3 2026.
Artiva Biotherapeutics made up ﹤0.01% of Bailard's portfolio in Q3 2026, its #733 holding.
Bailard first reported a position in Artiva Biotherapeutics in Q1 2026 and has held it in 3 quarters since.
Bailard's Artiva Biotherapeutics position peaked at $201K in Q2 2026.
3 funds tracked by Wall St. Rank held Artiva Biotherapeutics as of Q3 2026.

Based on Bailard's 13F filing for Q3 2026, filed 13 Oct 2026.